Birdwatch Note
2024-10-24 20:45:59 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
1.-Se trata de una población de estudio,reducida. 2.-El uso de estas medicaciones no es banal, sino peligrosa. Es evidente que el estudio refuerza la idea de su inutilidad y refuerza la necesidad de su abandono y prohibición para tales usos. https://biobiochile.cl/noticias/soci
Written by 25DA5F08CCC2C2F09C420B303BF75FB60629E2453ED9C6BCF93A272A18885F9C
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1849501711578046917
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1849552942887481596
- noteId - 1849552942887481596
- participantId -
- noteAuthorParticipantId - 25DA5F08CCC2C2F09C420B303BF75FB60629E2453ED9C6BCF93A272A18885F9C Participant Details
- createdAtMillis - 1729802759273
- tweetId - 1849501711578046917
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 1.-Se trata de una población de estudio,reducida. 2.-El uso de estas medicaciones no es banal, sino peligrosa. Es evidente que el estudio refuerza la idea de su inutilidad y refuerza la necesidad de su abandono y prohibición para tales usos. https://biobiochile.cl/noticias/soci
Note Ratings
| rated at | rated by | |
| 2024-10-24 20:57:23 -0500 | Rating Details | |
| 2024-10-24 20:57:15 -0500 | Rating Details | |
| 2024-10-24 18:24:23 -0500 | Rating Details | |
| 2024-10-24 17:56:08 -0500 | Rating Details | |
| 2024-10-24 17:39:13 -0500 | Rating Details | |
| 2024-10-24 19:34:56 -0500 | Rating Details | |
| 2024-10-24 21:17:55 -0500 | Rating Details | |
| 2024-10-24 21:09:22 -0500 | Rating Details | |
| 2024-10-24 18:36:10 -0500 | Rating Details | |
| 2024-10-24 18:03:43 -0500 | Rating Details | |
| 2024-10-24 17:50:31 -0500 | Rating Details | |
| 2024-10-24 15:59:30 -0500 | Rating Details | |
| 2024-10-24 20:58:36 -0500 | Rating Details | |
| 2024-10-24 15:58:44 -0500 | Rating Details | |
| 2024-10-24 15:50:46 -0500 | Rating Details | |
| 2024-10-24 20:48:03 -0500 | Rating Details | |
| 2024-10-24 20:08:31 -0500 | Rating Details |